Ian Goodwin

Director, Global Program Design, • Fujifilm Diosynth Biotechnologies

Ian Goodwin is a Director in the Viral Gene Therapy Global Program Design team at FUJIFILM Diosynth Biotechnologies (FDB), based in College Station, Texas. He has been at FDB for five years, having also served as Associate Principal Scientist Group Leader in the Process Development group. Ian is currently responsible for providing technical and project scope development support to prospective clients engaged in CDMO selection for viral and non-viral cell & gene therapy products. Ian’s previous experience includes nine years working on the process development and manufacturing of adeno-associated virus (AAV) and lentivirus vectors (LV) in academic, start-up, and CDMO environments. Ian holds a Master’s Degree in Microbiology and Immunology from Drexel University College of Medicine and a B.Sc in Microbiology from The University of Pittsburgh.

Also Speaking

Karen Walker

Chief Technical Officer • Kyverna Therapeutics

Neal Flomenberg

Chief Scientific Officer • Tevogen

Marco Ruella

Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies • University of Pennsylvania

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.